BMI1 and breast carcinoma: Additionally, robust evidence suggests that Bmi1 is critical to the invasive potential and contributes to tumorigenic capacity in colon cancer [10], medulloblastoma [11], laryngeal cancer [12], breast cancer [13], and prostate cancer [14].